These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 33438236)

  • 21. Angioedema After Squaric Acid Treatment in a 6-Year-Old Girl.
    Chen CA; Carlberg V; Kroshinsky D
    Pediatr Dermatol; 2017 Jan; 34(1):e44-e46. PubMed ID: 27699860
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Squaric acid dibutyl ester for the treatment of alopecia areata: A retrospective evaluation.
    Losol E; Şentürk N
    Dermatol Ther; 2021 Jan; 34(1):e14726. PubMed ID: 33377267
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Percutaneous penetration of squaric acid and its esters in hairless mouse and human skin in vitro.
    Sherertz EF; Sloan KB
    Arch Dermatol Res; 1988; 280(1):57-60. PubMed ID: 3355225
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Successful treatment of alopecia areata-like hair loss with the contact sensitizer squaric acid dibutylester (SADBE) in C3H/HeJ mice.
    Freyschmidt-Paul P; Sundberg JP; Happle R; McElwee KJ; Metz S; Boggess D; Hoffmann R
    J Invest Dermatol; 1999 Jul; 113(1):61-8. PubMed ID: 10417620
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cutaneous lymphoid hyperplasia related to squaric acid dibutyl ester.
    Millican EA; Conley JA; Sheinbein D
    J Am Acad Dermatol; 2011 Jul; 65(1):230-2. PubMed ID: 21679832
    [No Abstract]   [Full Text] [Related]  

  • 26. Treatment of alopecia areata with squaric acid dibutylester.
    Hill ND; Bunata K; Hebert AA
    Clin Dermatol; 2015; 33(3):300-4. PubMed ID: 25889130
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Topical squaric acid dibutylester therapy for alopecia areata.
    Flowers FP; Slazinski L; Fenske NA; Pullara TJ
    Cutis; 1982 Dec; 30(6):733-6. PubMed ID: 6756800
    [No Abstract]   [Full Text] [Related]  

  • 28. [Allergic disease caused by squaric acid dibutyl ester: description of 2 cases in a work environment].
    Todaro A; Nava C
    Med Lav; 1991; 82(3):276-9. PubMed ID: 1795673
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Contact allergy as a therapeutic tool for alopecia areata: application of squaric acid dibutylester.
    Happle R; Kalveram KJ; Büchner U; Echternacht-Happle K; Göggelmann W; Summer KH
    Dermatologica; 1980; 161(5):289-97. PubMed ID: 7439477
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Squaric acid dibutylester in alopecia areata: is discomfort really necessary?
    Orecchia G; Rabbiosi G
    J Am Acad Dermatol; 1987 Apr; 16(4):876. PubMed ID: 3571551
    [No Abstract]   [Full Text] [Related]  

  • 31. Treatment of severe alopecia areata with squaric acid dibutylester in pediatric patients.
    Orecchia G; Malagoli P; Santagostino L
    Pediatr Dermatol; 1994 Mar; 11(1):65-8. PubMed ID: 8170854
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Treatment of alopecia areata with squaric acid dibutylester.
    Caserio RJ
    Arch Dermatol; 1987 Aug; 123(8):1036-41. PubMed ID: 3307636
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Topical squaric acid dibutylester therapy for alopecia areata: a double-sided patient-controlled study.
    Chua SH; Goh CL; Ang CB
    Ann Acad Med Singap; 1996 Nov; 25(6):842-7. PubMed ID: 9055014
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The pattern and profile of alopecia areata in Singapore--a study of 219 Asians.
    Tan E; Tay YK; Goh CL; Chin Giam Y
    Int J Dermatol; 2002 Nov; 41(11):748-53. PubMed ID: 12452996
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Transient leucoderma appearing in an untreated area following contact immunotherapy for alopecia areata.
    Nasca MR; Micali G; Pulvirenti N; Licastro Cicero R
    Eur J Dermatol; 1998 Mar; 8(2):125-6. PubMed ID: 9649675
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Squaric acid esters in the treatment of alopecia areata.
    Barth JH; Darley CR; Gibson JR
    J Am Acad Dermatol; 1986 May; 14(5 Pt 1):846. PubMed ID: 3711389
    [No Abstract]   [Full Text] [Related]  

  • 37. Topical immunotherapy with squaric acid dibutylester: unusual hair pigmentary changes in two cases of alopecia areata.
    Mastrolonardo M; Diaferio A
    J Eur Acad Dermatol Venereol; 2002 Mar; 16(2):186. PubMed ID: 12046838
    [No Abstract]   [Full Text] [Related]  

  • 38. Treatment of alopecia areata with squaric acid dibutylester.
    Micali G; Cicero RL; Nasca MR; Sapuppo A
    Int J Dermatol; 1996 Jan; 35(1):52-6. PubMed ID: 8838932
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Topical therapy of alopecia areata with squaric acid dibutylester.
    Case PC; Mitchell AJ; Swanson NA; Vanderveen EE; Ellis CN; Headington JT
    J Am Acad Dermatol; 1984 Mar; 10(3):447-50. PubMed ID: 6725657
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Determination of in vivo dose response and allergen-specific T cells in subjects contact-sensitized to squaric acid dibutyl ester.
    Camouse MM; Swick AR; Ryan CA; Hulette B; Gerberick F; Tinkle SS; Nedorost ST; Cooper KD; Stevens SR; Baron ED
    Dermatitis; 2008; 19(2):95-9. PubMed ID: 18413111
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.